» Authors » Janet MacEachern

Janet MacEachern

Explore the profile of Janet MacEachern including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 94
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang Y, Guyatt G, Teich T, Dawdy J, Shahid S, Altman J, et al.
PLoS One . 2021 Mar; 16(3):e0249087. PMID: 33784346
To compare the effectiveness and safety of intensive antileukemic therapy to less-intensive therapy in older adults with acute myeloid leukemia (AML) and intermediate or adverse cytogenetics, we searched the literature...
2.
Sekeres M, Guyatt G, Abel G, Alibhai S, Altman J, Buckstein R, et al.
Blood Adv . 2020 Aug; 4(15):3528-3549. PMID: 32761235
Background: Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, patient goals, prognosis, and practitioner- and patient-perceived treatment risks and benefits...
3.
Rota S, Roma A, Dude I, Ma C, Stevens R, MacEachern J, et al.
Mol Cancer Ther . 2017 Aug; 16(11):2618-2626. PMID: 28835383
Acute myeloid leukemia (AML) is a devastating disease characterized by poor patient outcome and suboptimal chemotherapeutics. Here, a high-throughput screen identified diosmetin, a citrus flavonoid, with anti-AML activity. Diosmetin imparted...
4.
Rae C, Benger A, Fowler J, MacEachern J, Pullenayegum E, Stryker M, et al.
J Adolesc Young Adult Oncol . 2016 Jan; 5(2):174-80. PMID: 26812460
Purpose: Hodgkin lymphoma (HL) is the commonest cancer in adolescents and young adults (AYAs), aged 15-29 years. While the survival rate is high, many survivors experience adverse late effects of...
5.
Crump M, Herst J, Baldassarre F, Sussman J, MacEachern J, Hodgson D, et al.
Blood . 2015 Jan; 125(11):1708-16. PMID: 25605371
No abstract available.